GrowingStockReport.com

NASDAQ Decliners Watch List: China Information Technology, Inc. (NASDAQ:CNIT), Sinovac Biotech Ltd. (NASDAQ:SVA), and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 04/19/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding China Information Technology, Inc. (NASDAQ:CNIT), Sinovac Biotech Ltd. (NASDAQ:SVA), and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR).

China Information Technology, Inc. (NASDAQ:CNIT) a company that provides integrated solutions for the geographic information systems, digital public security technology, digital hospital information systems, education, media, and consumer product markets in the People’s Republic of China closed down in its previous session (-10.69%) on 513,621 shares traded. China Information Technology, Inc. (NASDAQ:CNIT) is currently down (-41.88%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about China Information Technology, Inc. (NASDAQ:CNIT)

Sinovac Biotech Ltd. (NASDAQ:SVA) a biopharmaceutical company that engages in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China closed down in its previous session (-9.93%) on 1,182,482 shares traded after Sinovac Reported Unaudited Fourth Quarter and Full Year 2012 Financial Results. Sinovac Biotech Ltd. (NASDAQ:SVA) is currently down (-30.26%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Sinovac Biotech Ltd. (NASDAQ:SVA)

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) a specialty pharmaceutical company that engages in the research, development, and commercialization of product candidates intended to address medication abuse and misuse utilizing its proprietary Aversion and Impede technologies closed down in its previous session (-8.33%) on 1,371,026 shares traded after ACURA PHARMACEUTICALS, INC Filed SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) is currently down (-44.44%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com